Loading your page…
Each register with its number of medicines and a few of them.
Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.
AEMPS · 44 medicines
CBG-MEB · 35 medicines
Health Canada · 34 medicines
MS · 32 medicines · Historical list
AIFA · 18 medicines
SFDA · 15 medicines · Historical list
EMA · 12 medicines
HALMED · 12 medicines
Show all 12HSA · 9 medicines
ALIMS · 8 medicines
PHARMAC · 7 medicines
Show all 7Every register, a page at a time. Strengths and packs are on each medicine’s page.
70 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Lamivudine | United States | 100MG, 150MG, 300MG | tablet | Marketed | Breckenridge |
| Lamivudine | United States | 10MG/ML | solution | Marketed | Chartwell Molecular |
| Lamivudine and ZidovudineCombination | United States | 150MG; 300MG | tablet | Marketed | Aurobindo Pharma |
| Lamivudine, Nevirapine and ZidovudineCombination | United States | 150MG; 200MG; 300MG | tablet | Not marketed | Micro Labs |
| Lamivudine; StavudineCombination | United States | 150MG; 30MG, 150MG; 40MG | tablet | Tentative approval | Matrix Labs |
| Lamivudine; ZidovudineCombination | United States | 30MG; 60MG | tablet | Tentative approval | Mylan Labs |
| Lamivudine; ZidovudineCombination | United States | 30MG; 60MG | tablet, for suspension | Tentative approval | Cipla Limited |
| Lamivudine; ZidovudineCombination | United States | 150MG; 300MG, 150MG; 300MG; 600MG, 30MG; 60MG | tablet | Tentative approval | Emcure Pharma |
| Lamivudine and StavudineCombination | United States | 150MG; 30MG, 150MG/30MG | tablet | Tentative approval | Macleods Pharma |
| Abacavir Sulfate and LamivudineCombination | United States | 600MG BASE; 300MG | tablet | Marketed | Aurobindo Pharma LTD |
| Lamivudine; Stavudine; NevirapineCombination | United States | 150MG; 30MG; 200MG, 150MG; 40MG; 200MG | tablet | Tentative approval | Cipla Limited |
| Lamivudine; Nevirapine; ZidovudineCombination | United States | 150MG; 200MG; 300MG | tablet | Tentative approval | Matrix Labs |
| Lamivudine; Nevirapine; ZidovudineCombination | United States | 30MG; 50MG; 60MG | tablet | Tentative approval | Cipla LTD |
| Lamivudine; Nevirapine; ZidovudineCombination | United States | 30MG; 50MG; 60MG | tablet, for suspension | Tentative approval | Strides Arcolab LTD |
| Lamivudine; Zidovudine; AbacavirCombination | United States | 150MG; 300MG; 300MG | tablet | Tentative approval | Aurobindo Pharma LTD |
| Lamivudine; Zidovudine; NevirapineCombination | United States | 150MG; 300MG; 200MG | tablet | Tentative approval | Cipla Limited |
| Lamivudine; Zidovudine; EfavirenzCombination | United States | 150MG; 300MG; 600MG | tablet | Tentative approval | Strides Acrolab |
| Lamivudine, Nevirapine, and StavudineCombination | United States | 150MG | tablet | Tentative approval | Macleods Pharma |
| Lamivudine, Nevirapine, and StavudineCombination | United States | 150MG; 200MG; 30MG | tablet | Tentative approval | Hetero Drugs LTD |
| Efavirenz, Lamivudine and Tenofovir Disoproxil FumarateCombination | United States | 400MG; 300MG; 300MG, 600MG; 300MG; 300MG | tablet | Marketed | Aurobindo Pharma LTD |
| Lamivudine/Nevirapine/Zidovudine TabletsCombination | United States | 30MG; 50MG; 60MG | tablet, for suspension | Tentative approval | Matrix Labs |
| Abacavir Sulfate and LamivudineCombination | United States | 60MG BASE; 30MG | tablet, for suspension | Not marketed | Pharmobedient |
| Lamivudine; Tenofovir Disoproxil FumarateCombination | United States | 300MG; 300MG | tablet | Tentative approval | Cipla Limited |
| Lamivudine and Tenofovir Disoproxil FumarateCombination | United States | 300MG; 300MG, 75MG; 75MG | tablet | Tentative approval | Aurobindo Pharma LTD |
| Lamivudine/Tenofovir Disoproxil Fumarate FDC TabsCombination | United States | 300MG/300MG | tablet | Tentative approval | Hetero Drugs LTD |
The same brand on several registers.
The companies holding its medicines, the most first.
Substances it shares a medicine with.
How the registers write it, in their own languages.
Compiled by Prognia from the public medicine registers of AEMPS, AIFA, ALIMS, Anvisa, CBG-MEB, EMA, FDA, HALMED, Health Canada, HSA, MS, PHARMAC and SFDA. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.
